These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 6438859

  • 21. Does 2-mercaptoethane sulphonate (mesna) prevent cyclophosphamide and azathioprine induced immunosuppression? In vitro studies.
    Al-Safi SA, Maddocks JL.
    Br J Clin Pharmacol; 1986 Mar; 21(3):267-70. PubMed ID: 2938613
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.
    Araujo CE, Tessler J.
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):195-201. PubMed ID: 6402369
    [Abstract] [Full Text] [Related]

  • 27. Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention.
    Cannon J, Linke CA, Cos LR.
    Urology; 1991 Nov; 38(5):413-6. PubMed ID: 1949449
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Electron microscopic investigations of the cyclophosphamide-induced lesions of the urinary bladder of the rat and their prevention by mesna.
    Themann H, Oberdorf E, Brock N, Pohl J.
    Urol Int; 1987 Nov; 42(1):37-43. PubMed ID: 3109094
    [Abstract] [Full Text] [Related]

  • 30. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
    Brock N, Pohl J, Stekar J.
    J Cancer Res Clin Oncol; 1981 Nov; 100(3):311-20. PubMed ID: 6792207
    [Abstract] [Full Text] [Related]

  • 31. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Miyata Y, Tsuda H, Matayoshi-Miyasato K, Fukushima S, Murasaki G, Ogiso T, Ito N.
    Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cyclophosphamide-induced water intoxication: treatment with fluid restriction and 2-mercaptoethane sulfonate.
    Haas A, Chin T, Stiehm ER.
    Am J Dis Child; 1986 Nov; 140(11):1094-5. PubMed ID: 3094362
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
    Iwasaku-Fujimoto M, Fujiwara F, Todo S, Morioka Y, Imashuku S.
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
    [Abstract] [Full Text] [Related]

  • 38. [Prevention of urotoxic complications during therapy with cytostatics. The problem of the interaction between sodium-II-mercaptoethanesulfonate and cyclophosphamide].
    Possinger K, Ehrhart H, Misera C, Hartenstein R.
    Fortschr Med; 1981 Oct 22; 99(40):1650-2. PubMed ID: 6795099
    [No Abstract] [Full Text] [Related]

  • 39. Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.
    Sangster G, Kaye SB, Calman KC, Dalton JF.
    Eur J Cancer Clin Oncol; 1984 Mar 22; 20(3):435-6. PubMed ID: 6423391
    [No Abstract] [Full Text] [Related]

  • 40. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
    Grubbs CJ, Juliana MM, Eto I, Casebolt T, Whitaker LM, Canfield GJ, Manczak M, Steele VE, Kelloff GJ.
    Anticancer Res; 1993 Mar 22; 13(1):33-6. PubMed ID: 8476227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.